Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer harboring one or ...

It is not unusual for advanced prostate cancer to become resistant to treatment. Of these resistant cases, some progress to a specific form of the disease, | Genetics And Genomics ...

PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR 0.72) versus SoC alone, with positive trend in OS (HR 0.84) in PSMA+ metastatic ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.

In men with prostate cancer, prophylactic whole pelvic radiotherapy does not improve OS compared to prostate-only dose-escalated radiotherapy.

From 2003-2017, incidence rates for six of 13 cancers assessed rose among younger adults (ages 20-49) in over 75% of the countries studied, reported Amy Berrington de Gonzalez, DPhil, of the Institute ...

Patriots coach Mike Vrabel shared a positive update on defensive coordinator Terrell Williams, who is battling prostate cancer.

Scientists have discovered that pairing two cancer medicines already in use could offer new hope for men battling advanced prostate cancer. The breakthrough research from the Institute of Cancer ...

Former UK Prime Minister Rishi Sunak has emphasised the life-saving potential of early prostate cancer detection. Highlighting the importance of targeted screening, he said men at high risk, ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...

Rep. Cynthia Roe (R-Lindsay) hosted an interim study Thursday exploring policy solutions related to lung cancer prevention, treatment and health equity.